‌

US Patent 8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

Patent 8871250 was granted and assigned to Oncothyreon on October, 2014 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

B. Michael Longenecker0

Date of Patent

October 28, 2014

Patent Application Number

11475250

Date Filed

June 27, 2006

Patent Primary Examiner

No article content yet.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.